About CAM Cancer

CAM Cancer provides health professionals with high-quality, evidence-based information about complementary and alternative medicine (CAM) in the supportive/palliative care, treatment or prevention of cancer. CAM Cancer is managed by NAFKAM who coordinates the worldwide network of experts in CAM and/or cancer care producing and disseminating reliable information.

Image
Photos showing woman meditating, herbs and pills, acupuncture needles, and a patient consulting healthcare professionals
Different CAM modalities and usage situations. Collage by Tine L.Bergli, photos from Mostphotos.com

Go directly to: Aims - The CAM Cancer Collaboration - Funding - Advisory Committee - Editorial team - Official partners - Authors and reviewers

Originally funded by the European Commission (EC) within the Framework 5 Programme, CAM Cancer has been managed by the National Research Center for Complementary and Alternative Medicine (NAFKAM) since 2007.

NAFKAM coordinates a worldwide network of experts in CAM and/or cancer care for the CAM Cancer Collaboration in order to produce evidence-based information on CAM for cancer thus contributing to safe and evidence-based cancer care.

NAFKAM maintains and develops the website and its content, as part of its programme of summarizing and disseminating the research status of CAM to health professionals. NAFKAM is located at the Department of Community Medicine at the Faculty of Health Sciences, UiT The Arctic University of Norway.

Aims

The aims of CAM Cancer are:

  • To prepare and disseminate information for health professionals based on the best available evidence. Health professionals can use this to make informed treatment decisions together with their patients. You can access the free database here.
  • Maintaining and developing an international authoritative network around CAM in cancer. You can find out more about the CAM Cancer Collaboration here.

The CAM Cancer database

CAM Cancer's core output is the freely accessible database of CAM Cancer summaries published on this website. It can be accessed for free on this website by searching for treatments, symptoms or cancer types.

 

The CAM Cancer Collaboration

NAFKAM manages the CAM Cancer Collaboration supporting to fulfil the aims of CAM Cancer. The Collaboration is led by the advisory committee, scientific coordinator, editorial team, and a network of official partnersAuthors and reviewers are recruited from the Collaboration and beyond. including researchers, clinicians, oncologists, and representatives of national cancer societies.

Funding

CAM-Cancer is entirely nonprofit. It receives no commercial funding or funding from any institution with a conflict of interest. The main funders of CAM-Cancer are currently NAFKAM, as well as the German Society of Hematology and Medical Oncology (DGHO) and Swiss Cancer League/ Swiss Cancer Research:

  • NAFKAM is funded directly by the Norwegian government’s Directorate of Health. NAFKAM does not endorse or recommend any treatment/ therapy or any individual/ organisation providing therapy. NAFKAM’s research and information services are entirely non-profit and independent. NAFKAM’s websites do not offer advertisement of any kind.
  • The German Society of Hematology and Medical Oncology (DGHO) is an organization of scientists and physicians specializing in the research, diagnosis and treatment of blood diseases and malignant solid tumors.
  • The Swiss Cancer League/ Swiss Cancer Research is a national charitable organisation fighting against cancer and supporting patients and their relatives.

Advisory Committee

  • Miek Jong PhD
    Chair of the Advisory Committee and Director of NAFKAM
  • Thomas Cerny MD
    Head of Oncology and Hematology Department, Kantonsspital St.Gallen; President Cancer Research Switzerland; President Oncosuisse, Switzerland (
    Swiss Cancer League)
  • Edzard Ernst MD, PhD, FMEdSci, FSB, FRCP, FRCPEd
    Emeritus Professor, University of Exeter Medical School, UK 
  • Vinjar Fonnebo MD, MSc Epidemiology, PhD
    Professor of Preventive Medicine and Head of the Department of Clinical Medicine, UiT The Arctic University of Norway
  • Markus Horneber MD
    Senior Physician, 
    Department of Oncology and Hematology, Klinikum Nürnberg, Germany

Editorial team

Scientific Co-ordinator and Senior Editor

Barbara Wider MA MA
NAFKAM, UiT The Arctic University of Norway

Technical Editor

Ola Lillenes BA
Head of Communications, NAFKAM and Chief Editor of Norway's national information service for complementary and alternative medicine

Responsible Editors

  • Edzard Ernst MD, PhD, FMEdSci, FSB, FRCP, FRCPEd
    Emeritus Professor, University of Exeter Medical School, UK 
  • Moshe Frenkel MD
    Chair of The Israeli Society of Complementary Medicine; Clinical Associate Professor, University of Texas Medical Branch, USA; Director of Integrative Oncology Service, Institute of Oncology, Meir Medical Center, Kfar Saba, Israel 
  • Markus Horneber MD
    Senior Physician, Department of Oncology and Hematology, Klinikum Nürnberg, Germany 
  • Karen Pilkington BPharm, MSc, PhD, MRPharmS, FHEA
    Senior Research Fellow, Faculty of Science and Technology, University of Westminster, London, UK 

Pharmacology Editors

  • Christoph Ritter PhD
    Professor of Clinical Pharmacy, Ernst-Moritz-Arndt-University of Greifswald, Germany
  • Janine Ziemann Dipl. Pharmacist
    Research Fellow, Ernst-Moritz-Arndt-University of Greifswald, Germany

Support staff

  • Leala Watson – literature searches
  • Tine Lillegård Bergli - information specialist, NAFKAM
  • Annikken Cecilie Pettersen - information specialistNAFKAM

Official partners

Authors and reviewers

The following people have acted as authors on the CAM Cancer project:

  • Katja Boehm PhD MSc Health Psychology
    Research Fellow, University of Witten/Herdecke, Chair of Medical Theory, Integrative Medicine and Anthroposophy, Germany 
  • Joke Bradt PhD, MT-BC
    Associate Professor, Department of Creative Arts Therapies, College of Nursing and Health Professions, Drexel University, Philadelphia, USA.
  • Italo M Cesari PhD
    Emeritus Professor, Cancer Biochemistry and Molecular Biology Laboratory, Institute of Biochemistry Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Brazil 
  • Ellen Conte ND
    Clinician Scientist, Ottawa Integrative Cancer Centre, Ottawa ON, Canada
  • Helen Cooke MA, BSc
    Integrative Health Advisor, Freelance, UK 
  • Holger Cramer MSc PhD
    Associate Professor (Privatdozent) and Research Director of the Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Germany
  • Gabriele Dennert MD, MSc (Public Health)
    Professor (Public Health and Social Medicine), University of Applied Sciences and Arts Dortmund, Faculty of Applied Social Sciences, Germany
  • Liene Dhooghe MSc, PhD
    Post-doctoral Researcher, University of Antwerp, Belgium 
  • Edzard Ernst MD, PhD, FMEdSci, FSB, FRCP, FRCPEd
    Emeritus Professor, University of Exeter Medical School, UK 
  • Vinjar Fonnebo MD, MSc Epidemiology, PhD
    Professor of Preventive Medicine and Head of Institute of Community Medicine, UiT The Arctic University of Norway
  • Luc Geeraert MSc
    Scientific writer, Freelance, Belgium 
  • Arne Heyerick PhD
    Program Manager Droia, Strombeek-Bever, Belgium 
  • Markus Horneber MD
    Senior Physician, Department of Oncology and Hematology, Klinikum Nürnberg, Germany 
  • Rachel Jolliffe MSc
    Research and Evaluation Officer, Penny Brohn Cancer Care, UK
  • Alexander Kalisch MD
    Consultant Oncologist, Klinikum Nürnberg, Germany 
  • Karl Krumwiede PhD/Dr oec. troph.
    Ecotrophologist (household economics, nutrition and food science), Klinikum Nürnberg, Germany 
  • Xi Lin PhD
    Research Assistant, Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 
  • Jianping Liu PhD
    Director of the Centre for Evidence-Based Chinese Medicine, Professor in Clinical Epidemiology, Beijing, China
  • Ava Lorenc PhD
    Honorary Senior Research Associate, Population Health Sciences, University of Bristol, UK
  • Ann-Christine Moenaert MSc
    Project Manager, Anticancer Fund, Brussels, Belgium 
  • Thomas Ostermann PhD
    Professor of Research Methods and Information Systems in Complementary Medicine, Faculty of Health, Chair of Medical Theory, Integrative and Anthroposophical Medicine, University of Witten/Herdecke, Germany 
  • Karen Pilkington BPharm, MSc, PhD, MRPharmS, FHEA
    Senior Research Fellow, Faculty of Science and Technology, University of Westminster, London, UK 
  • Pawel Posadzki PhD
    Freelance Systematic Reviewer, York, UK
  • Peter Renner MD
    Physician, Department of Oncology and Hematology, Klinikum Nürnberg, Germany 
  • Klara Rombauts MSc
    Project Manager, Anticancer Fund, Strombeek-Bever, Belgium 
  • Helen Seers PhD
    Research Fellow, Penny Brohn Cancer Care, UK
  • Michaela Sieh MD
    Reliable Cancer Therapies, Belgium 
  • Sarah Vadeboncoeur ND, BSc
    Naturopathic Doctor, Ottawa Integrative Health Centre, Canada
  • Mirjam Wüsthof MD
    University Cancer Centre, Hamburg, Germany 

The following people have acted as reviewers on the CAM Cancer project.

  • Arends, Jann (Germany)
  • Awang, Dennis (Canada)
  • Balneaves, Lynda (Canada)
  • Baum, Michael (UK)
  • Benton, Deborah (USA)
  • Biesalski, Hans (Germany)
  • Boehm, Katja (Germany)
  • Boon, Heather (Canada)
  • Braun, Lesley (Australia)
  • Brignall, Matt (USA)
  • Cerny, Thomas (Switzerland)
  • Christensen, Søren Brøgger (Denmark)
  • Cooke, Helen (UK)
  • Conte, Ellen (Canada)
  • van Dam, Frits (The Netherlands)
  • Dennert, Gabriele (Germany)
  • Dhooghe, Liene (Belgium)
  • Elkins, Gary (USA)
  • Ernst, Edzard (UK)
  • Fønnebø, Vinjar (Norway)
  • Green, Julia (UK)
  • Horneber, Markus (Germany)
  • Huber, Roman (Germany)
  • Hübner, Jutta (Germany)
  • Huntley, Alyson (UK)
  • Jacobson, Judith (USA)
  • Johannessen, Helle (Denmark)
  • Jolliffe, Rachel (UK)
  • Jungi, Felix (Switzerland)
  • Kaemmerer, Ulrike (Germany)
  • Kraft, Karin (Germany)
  • Lampe, Hans (Germany)
  • Langhorst, Jost (Germany)
  • Lejeune, Stephane (Belgium)
  • Liu, Jianping (China)
  • Manuel-y-Keenoy, Begoña (Belgium)
  • Marinakis, Christiana (Denmark)
  • Meheus, Lydie (Belgium)
  • Mukhtar, Hasan (USA)
  • Musial, Frauke (Norway)
  • Newman, Robert (USA)
  • Olsen, Anja (Denmark)
  • Oneschuk, Doreen (USA)
  • Paludan-Müller, Christine (Denmark)
  • Philipp, Thomas (Germany)
  • Pilkington, Karen (UK)
  • Posadzki, Pawel, York, UK
  • Rombauts, Klara (Belgium)
  • Rossion, Inga (Germany)
  • Rostock, Matthias (Switzerland)
  • Scraub, Simon (France)
  • Seely, Dugald (Canada)
  • Seers, Helen (UK)
  • Stacpoole, Peter (USA)
  • Stapf, Adele (Germany)
  • Stevinson, Clare (UK)
  • Templeton, Arnoud (Switzerland)
  • Tjoenneland, Anne (Denmark)
  • Ulrich-Merzenich, Gudrun (Germany)
  • Wardell, Diane (USA)
  • Weitzman, Sheila (Canada)

CAM Cancer is hosted by NAFKAM

Norway's National Research Center in Complementary and Alternative Medicine

Read more about NAFKAM

Other websites from NAFKAM: